Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement

Franz Josef Neumann, Walter Desmet, Eberhard Grube, Johannes Brachmann, Patrizia Presbitero, Paolo Rubartelli, Andreas Mügge, Francesco Di Pede, Diana Füllgraf, Wim Aengevaeren, Leonardo Spedicato, Jeffrey J. Popma

Research output: Contribution to journalArticle

Abstract

Background-In-stent restenosis is notoriously difficult to treat by repeat catheter intervention because of its propensity for aggressive recurrent neointimal formation. This study sought to assess the effectiveness and safety of the sirolimus-eluting stent in the treatment of in-stent restenosis. Methods and Results-The study was designed as a prospective multicenter registry. We included 162 patients with in-stent restenosis of a native coronary artery who had a clinical indication for repeat intervention. Patients were scheduled for follow-up angiography at 6 months. The primary end point was in-lesion late loss. Follow-up angiography was performed in 155 patients. We obtained an in-lesion late loss of 0.08±0.49 mm and a binary restenosis rate of 9.7% (15/155), which prompted reintervention in 7.4% (12/162) at 9 months. The 9-month rate of death was 1.2% (2/162) and that of nonfatal myocardial infarction was 1.2% (2/162). Conclusions-Sirolimus-eluting stents were highly efficacious and safe in the treatment of in-stent restenosis. Our study provides rationale for the use of sirolimus-eluting stents in the treatment of in-stent restenosis.

Original languageEnglish
Pages (from-to)2107-2111
Number of pages5
JournalCirculation
Volume111
Issue number16
DOIs
Publication statusPublished - Apr 26 2005

Fingerprint

Coronary Restenosis
Sirolimus
Stents
Safety
Therapeutics
Angiography
Registries
Coronary Vessels
Catheters
Myocardial Infarction
Mortality

Keywords

  • Restenosis
  • Sirolimus
  • Stents

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Neumann, F. J., Desmet, W., Grube, E., Brachmann, J., Presbitero, P., Rubartelli, P., ... Popma, J. J. (2005). Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation, 111(16), 2107-2111. https://doi.org/10.1161/01.CIR.0000162467.53001.6B

Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. / Neumann, Franz Josef; Desmet, Walter; Grube, Eberhard; Brachmann, Johannes; Presbitero, Patrizia; Rubartelli, Paolo; Mügge, Andreas; Di Pede, Francesco; Füllgraf, Diana; Aengevaeren, Wim; Spedicato, Leonardo; Popma, Jeffrey J.

In: Circulation, Vol. 111, No. 16, 26.04.2005, p. 2107-2111.

Research output: Contribution to journalArticle

Neumann, FJ, Desmet, W, Grube, E, Brachmann, J, Presbitero, P, Rubartelli, P, Mügge, A, Di Pede, F, Füllgraf, D, Aengevaeren, W, Spedicato, L & Popma, JJ 2005, 'Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement', Circulation, vol. 111, no. 16, pp. 2107-2111. https://doi.org/10.1161/01.CIR.0000162467.53001.6B
Neumann, Franz Josef ; Desmet, Walter ; Grube, Eberhard ; Brachmann, Johannes ; Presbitero, Patrizia ; Rubartelli, Paolo ; Mügge, Andreas ; Di Pede, Francesco ; Füllgraf, Diana ; Aengevaeren, Wim ; Spedicato, Leonardo ; Popma, Jeffrey J. / Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. In: Circulation. 2005 ; Vol. 111, No. 16. pp. 2107-2111.
@article{f9ec4f9d590b4c448abc7812680ef719,
title = "Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement",
abstract = "Background-In-stent restenosis is notoriously difficult to treat by repeat catheter intervention because of its propensity for aggressive recurrent neointimal formation. This study sought to assess the effectiveness and safety of the sirolimus-eluting stent in the treatment of in-stent restenosis. Methods and Results-The study was designed as a prospective multicenter registry. We included 162 patients with in-stent restenosis of a native coronary artery who had a clinical indication for repeat intervention. Patients were scheduled for follow-up angiography at 6 months. The primary end point was in-lesion late loss. Follow-up angiography was performed in 155 patients. We obtained an in-lesion late loss of 0.08±0.49 mm and a binary restenosis rate of 9.7{\%} (15/155), which prompted reintervention in 7.4{\%} (12/162) at 9 months. The 9-month rate of death was 1.2{\%} (2/162) and that of nonfatal myocardial infarction was 1.2{\%} (2/162). Conclusions-Sirolimus-eluting stents were highly efficacious and safe in the treatment of in-stent restenosis. Our study provides rationale for the use of sirolimus-eluting stents in the treatment of in-stent restenosis.",
keywords = "Restenosis, Sirolimus, Stents",
author = "Neumann, {Franz Josef} and Walter Desmet and Eberhard Grube and Johannes Brachmann and Patrizia Presbitero and Paolo Rubartelli and Andreas M{\"u}gge and {Di Pede}, Francesco and Diana F{\"u}llgraf and Wim Aengevaeren and Leonardo Spedicato and Popma, {Jeffrey J.}",
year = "2005",
month = "4",
day = "26",
doi = "10.1161/01.CIR.0000162467.53001.6B",
language = "English",
volume = "111",
pages = "2107--2111",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement

AU - Neumann, Franz Josef

AU - Desmet, Walter

AU - Grube, Eberhard

AU - Brachmann, Johannes

AU - Presbitero, Patrizia

AU - Rubartelli, Paolo

AU - Mügge, Andreas

AU - Di Pede, Francesco

AU - Füllgraf, Diana

AU - Aengevaeren, Wim

AU - Spedicato, Leonardo

AU - Popma, Jeffrey J.

PY - 2005/4/26

Y1 - 2005/4/26

N2 - Background-In-stent restenosis is notoriously difficult to treat by repeat catheter intervention because of its propensity for aggressive recurrent neointimal formation. This study sought to assess the effectiveness and safety of the sirolimus-eluting stent in the treatment of in-stent restenosis. Methods and Results-The study was designed as a prospective multicenter registry. We included 162 patients with in-stent restenosis of a native coronary artery who had a clinical indication for repeat intervention. Patients were scheduled for follow-up angiography at 6 months. The primary end point was in-lesion late loss. Follow-up angiography was performed in 155 patients. We obtained an in-lesion late loss of 0.08±0.49 mm and a binary restenosis rate of 9.7% (15/155), which prompted reintervention in 7.4% (12/162) at 9 months. The 9-month rate of death was 1.2% (2/162) and that of nonfatal myocardial infarction was 1.2% (2/162). Conclusions-Sirolimus-eluting stents were highly efficacious and safe in the treatment of in-stent restenosis. Our study provides rationale for the use of sirolimus-eluting stents in the treatment of in-stent restenosis.

AB - Background-In-stent restenosis is notoriously difficult to treat by repeat catheter intervention because of its propensity for aggressive recurrent neointimal formation. This study sought to assess the effectiveness and safety of the sirolimus-eluting stent in the treatment of in-stent restenosis. Methods and Results-The study was designed as a prospective multicenter registry. We included 162 patients with in-stent restenosis of a native coronary artery who had a clinical indication for repeat intervention. Patients were scheduled for follow-up angiography at 6 months. The primary end point was in-lesion late loss. Follow-up angiography was performed in 155 patients. We obtained an in-lesion late loss of 0.08±0.49 mm and a binary restenosis rate of 9.7% (15/155), which prompted reintervention in 7.4% (12/162) at 9 months. The 9-month rate of death was 1.2% (2/162) and that of nonfatal myocardial infarction was 1.2% (2/162). Conclusions-Sirolimus-eluting stents were highly efficacious and safe in the treatment of in-stent restenosis. Our study provides rationale for the use of sirolimus-eluting stents in the treatment of in-stent restenosis.

KW - Restenosis

KW - Sirolimus

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=20244388656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244388656&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000162467.53001.6B

DO - 10.1161/01.CIR.0000162467.53001.6B

M3 - Article

C2 - 15851617

AN - SCOPUS:20244388656

VL - 111

SP - 2107

EP - 2111

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -